Bristol-Myers Squibb (BMY) News Today $59.01 -1.27 (-2.11%) Closing price 03/14/2025 03:59 PM EasternExtended Trading$59.10 +0.09 (+0.16%) As of 03/14/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Sienna Gestion Raises Stock Position in Bristol-Myers Squibb (NYSE:BMY)Sienna Gestion raised its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 722.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 158,299 shares of the biopharmaceutical company's stock after purchasing anMarch 15 at 7:01 AM | marketbeat.com7,804 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Atala Financial IncAtala Financial Inc bought a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 7,804 shares of the biopharmaceutical company's stock, valued at approximately $441,000. Several other hedge fuMarch 15 at 5:58 AM | marketbeat.comLbp Am Sa Has $24.84 Million Position in Bristol-Myers Squibb (NYSE:BMY)Lbp Am Sa boosted its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 26.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 439,119 shares of the biopharmaceutical company's stock after buying an additional 90,586 shares duMarch 15 at 5:57 AM | marketbeat.comIntegras Partners LLC Makes New Investment in Bristol-Myers Squibb (NYSE:BMY)Integras Partners LLC bought a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 49,073 shares of the biopharmaceutical company's stock, valued at approximately $2,776,March 15 at 5:57 AM | marketbeat.comImpact Capital Partners LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY)Impact Capital Partners LLC acquired a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 6,479 shares of the biopharmaceutical company's stockMarch 15 at 5:40 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Bought by Commonwealth Equity Services LLCCommonwealth Equity Services LLC grew its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 8.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,274,448 shares of the biopharmaceutical company's stoMarch 15 at 5:40 AM | marketbeat.comPGGM Investments Has $5.15 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)PGGM Investments grew its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 17.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 91,111 shares of the biopharmaceuticalMarch 15 at 5:31 AM | marketbeat.comErste Asset Management GmbH Decreases Holdings in Bristol-Myers Squibb (NYSE:BMY)Erste Asset Management GmbH decreased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 6.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 162,210 shares of the biopharmaceutical companyMarch 15 at 5:15 AM | marketbeat.comAchmea Investment Management B.V. Purchases 25,429 Shares of Bristol-Myers Squibb (NYSE:BMY)Achmea Investment Management B.V. raised its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 12.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 237,059 shares of the biophaMarch 15 at 5:14 AM | marketbeat.comWilliam Blair Has Positive Outlook for BMY Q2 EarningsMarch 15 at 2:07 AM | americanbankingnews.comBristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL TreatmentMarch 14 at 3:10 PM | finance.yahoo.com2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVTMarch 14 at 11:24 AM | businesswire.comEuropean Commission expands approval for Bristol Myers Squibb’s lymphoma therapyMarch 14 at 10:09 AM | in.investing.comBristol Myers announces EC approval of BreyanziMarch 14 at 10:09 AM | markets.businessinsider.comBristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell ...March 14 at 7:14 AM | gurufocus.comWilliam Blair Issues Optimistic Outlook for BMY EarningsBristol-Myers Squibb (NYSE:BMY - Free Report) - Investment analysts at William Blair upped their Q2 2025 earnings per share estimates for Bristol-Myers Squibb in a note issued to investors on Tuesday, March 11th. William Blair analyst M. Phipps now anticipates that the biopharmaceutical company wMarch 14 at 7:12 AM | marketbeat.comBristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular LymphomaMarch 14 at 6:59 AM | businesswire.comSkandinaviska Enskilda Banken AB publ Acquires 856,640 Shares of Bristol-Myers Squibb (NYSE:BMY)Skandinaviska Enskilda Banken AB publ lifted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 171.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,357,306 shares of the biopharmaceutical company'March 14 at 6:17 AM | marketbeat.comEssential Planning LLC. Takes $384,000 Position in Bristol-Myers Squibb (NYSE:BMY)Essential Planning LLC. acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 6,870 shares of the biopharmaceutical company's stock, valued at approximMarch 14 at 4:53 AM | marketbeat.comFarther Finance Advisors LLC Sells 19,032 Shares of Bristol-Myers Squibb (NYSE:BMY)Farther Finance Advisors LLC lessened its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 45.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,540 shares of the bioMarch 14 at 4:37 AM | marketbeat.comWilliam Blair Has Positive Outlook for BMY Q3 EarningsMarch 14 at 2:43 AM | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: Ascend Wellness Holdings LLC (OtherAAWH), Bristol-Myers Squibb (BMY) and Caribou Biosciences (CRBU)March 13 at 7:02 PM | markets.businessinsider.comBristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key FactsMarch 13 at 7:02 PM | msn.comWilliam Blair Issues Positive Estimate for BMY EarningsBristol-Myers Squibb (NYSE:BMY - Free Report) - Research analysts at William Blair lifted their Q3 2026 earnings per share estimates for Bristol-Myers Squibb in a report issued on Tuesday, March 11th. William Blair analyst M. Phipps now expects that the biopharmaceutical company will earn $1.66 pMarch 13 at 7:43 AM | marketbeat.comWith Nasdaq 100 in Correction, 4 High-Yield Dividend Giants Are Near 52-Week HighsMarch 13 at 6:47 AM | 247wallst.comSwiss National Bank Has $323.94 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)Swiss National Bank decreased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 4.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,727,400 shares of the biopharmaceutical company's stock after selling 2March 13 at 5:39 AM | marketbeat.comAvantax Advisory Services Inc. Acquires 33,423 Shares of Bristol-Myers Squibb (NYSE:BMY)Avantax Advisory Services Inc. raised its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 18.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 218,223 shares of the biopharmaceutical company's stock after acquiring an additional 33,42March 13 at 5:30 AM | marketbeat.comSequoia Financial Advisors LLC Purchases 8,745 Shares of Bristol-Myers Squibb (NYSE:BMY)Sequoia Financial Advisors LLC lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 6.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 151,700 shares of the biopharmaceutiMarch 13 at 4:51 AM | marketbeat.comCautious Outlook on Bristol-Myers Squibb Due to Cobenfy’s Uncertain Future and Reliance on Trial OutcomesMarch 12 at 9:38 PM | tipranks.comBristol-Myers Squibb Company (BMY) Presents at Leerink Partners 2025 Global Healthcare Conference (Transcript)March 12 at 6:32 PM | seekingalpha.comBristol-Myers Squibb Co Chart AnalysisMarch 12 at 3:29 PM | talkmarkets.comIs Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds?March 12 at 2:57 PM | insidermonkey.comMoors & Cabot Inc. Raises Position in Bristol-Myers Squibb (NYSE:BMY)Moors & Cabot Inc. grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 14.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 89,229 shares of the biopharmaceutical company's stockMarch 12 at 6:14 AM | marketbeat.comNatural Investments LLC Invests $393,000 in Bristol-Myers Squibb (NYSE:BMY)Natural Investments LLC acquired a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,956 shares of the biopharmaceutMarch 12 at 5:50 AM | marketbeat.comAGF Management Ltd. Increases Holdings in Bristol-Myers Squibb (NYSE:BMY)AGF Management Ltd. raised its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 8.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 607,064 shares of the biopharmaceutical company's stock after buyinMarch 12 at 5:47 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by River Road Asset Management LLCRiver Road Asset Management LLC cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 15.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 182,484 shares of the biopharmaceutical companyMarch 12 at 5:21 AM | marketbeat.comIndependent Advisor Alliance Has $4.02 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Independent Advisor Alliance boosted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 55.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 71,049 shares of the biopharmaceutical company's stock after buying an additional 25,330 shMarch 12 at 5:03 AM | marketbeat.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc.March 11, 2025 | prnewswire.comBristol-Myers Squibb (NYSE:BMY) Stock Holdings Increased by Donaldson Capital Management LLCDonaldson Capital Management LLC lifted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 61.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 59,395 shares of the biopharmaceutical compMarch 11, 2025 | marketbeat.comMiller Financial Services LLC Takes $990,000 Position in Bristol-Myers Squibb (NYSE:BMY)Miller Financial Services LLC purchased a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 17,495 shares of the biopharmaceutical company's stock, valued aMarch 11, 2025 | marketbeat.comPzena Investment Management LLC Sells 900,447 Shares of Bristol-Myers Squibb (NYSE:BMY)Pzena Investment Management LLC lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 6.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 13,301,299 shares of the biopharmaceuticalMarch 11, 2025 | marketbeat.comRiverbend Wealth Management LLC Invests $436,000 in Bristol-Myers Squibb (NYSE:BMY)Riverbend Wealth Management LLC purchased a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 7,692 shares of the biopharmaceutical company's stock, valued at apMarch 11, 2025 | marketbeat.comDaiwa Securities Group Inc. Cuts Stock Position in Bristol-Myers Squibb (NYSE:BMY)Daiwa Securities Group Inc. lowered its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 321,995 shares of the biopharmaceutical company's stock after selling 8,19March 11, 2025 | marketbeat.comAlphaQuest LLC Acquires 6,595 Shares of Bristol-Myers Squibb (NYSE:BMY)AlphaQuest LLC raised its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 54.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,751 shares of the biopharmaceutical company's stoMarch 11, 2025 | marketbeat.comBristol Myers to acquire cell therapy partner 2seventy bio in $286M all-cash dealMarch 11, 2025 | msn.com2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers SquibbMarch 10, 2025 | businesswire.comBristol Myers Unveils Positive Phase 3 Results for Sotyktu in Psoriatic ArthritisMarch 10, 2025 | benzinga.comBristol Myers announces data from Phase 3 POETYK PsA-2March 10, 2025 | markets.businessinsider.comBristol-Myers Squibb Company (BMY): One of the Best Performing Dividend Stocks to Buy NowMarch 10, 2025 | insidermonkey.comRecession Could Be Coming: 5 Strong Buy High-Yield Dividend Stocks That Will Still OutperformMarch 10, 2025 | 247wallst.com Remove Ads Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address BMY Media Mentions By Week BMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼1.220.73▲Average Medical News Sentiment BMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼7732▲BMY Articles Average Week Remove Ads Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Supernus Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 3/15/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
